Navigation Links
Yashoda Cancer Institute Commences Radiosurgery Treatments Using Varian Clinac Linear Accelerator
Date:7/14/2014

HYDERABAD, India, July 14, 2014 /PRNewswire/ -- Clinicians at a leading cancer center in India have become the first in the country to commence advanced lung, liver and brain radiotherapy treatments using an upgraded Clinac® medical linear accelerator from Varian Medical Systems (NYSE: VAR). The accelerator has been enhanced with High Intensity Mode dose delivery capability, which is allowing doctors at Yashoda Cancer Institute to shorten treatment times and deliver stereotactic body radiotherapy and stereotactic radiosurgery for hard to treat tumors.

Stereotactic body radiotherapy and stereotactic radiosurgery involve delivering the total dose in fewer treatment sessions, with a greater portion of the dose delivered each session. This means conventional treatment times of five to six weeks can be reduced to just a few days. At Yashoda, stereotactic treatments are used for lung, liver, spinal and cranial treatments.

"We are a high volume center treating up to 20 stereotactic radiosurgery patients each month and by using the new High Intensity Mode we are able to treat these patients in a conventional treatment slot of about 15 minutes," says Dr. G. S. Rao, managing director of Yashoda Cancer Institute. "This is really pretty amazing and would have been unheard of a few years ago."

Dr. Rao said the High Intensity Mode has an especially important role to play for elderly lung cancer patients who are considered inoperable, offering them an alternative to surgery. The patients also benefit, he says, from their total dose being delivered in fewer treatment sessions. "This greatly reduces the number of times the patient needs to visit the hospital meaning they can get back to their normal routine in a much shorter time," said Dr. Rao.

Yashoda combines the higher delivery doses offered by the High Intensity Mode upgrade with image-guided RapidArc® radiotherapy, which the hospital began delivering in 2008, making it the first in Asia to do so. With RapidArc, the machine quickly delivers the treatment while continuously rotating around the patient, and the beam is constantly shaped and reshaped during the rotation to match the shape and size of the tumor.

Yashoda Cancer Institute hosted a seminar on High Intensity Mode Radiosurgery at the Hyatt Park Hotel in Hyderabad yesterday. Clinicians from across Asia attended the event to share experiences and hear from some the leading exponents in radiosurgery from across the world. The inauguration ceremony was headed by the Honorable First Chief Minister of Telangana State, Sri K. Chandrasekhar Rao Garu.   

"Varian is the world leader in radiotherapy and radiosurgery technology and we have pioneered high intensity dose delivery for our family of medical linear accelerators, enabling clinicians to deliver up to 2400 monitor units of radiation per minute when appropriate," says Ashok Kakkar, Varian's senior managing director in India. "That delivery speed is unmatched in the industry. Treating patients with high intensity beams requires careful and precise patient setup and monitoring, which is aided by our robotically controlled image guidance solution."

"Around the world, as at Yashoda Institute, these advanced capabilities are enabling fast and precise treatments for a range of indications, particularly lung and liver cancer that have traditionally been difficult to treat curatively with traditional radiotherapy."

He said thousands of installed Varian Clinac linear accelerators are potential candidates for upgrades with High Intensity Mode technology and the clinical advantages this technology brings.

Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068

About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes, digital detectors, and image processing software and workstations for X-ray imaging in medical, scientific, and industrial applications, and also supplies high-energy X-ray devices for cargo screening and non-destructive testing applications.  Varian Medical Systems employs approximately 6,500 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit http://www.varian.com or follow us on Twitter.


'/>"/>
SOURCE Varian Medical Systems
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Veran Medical Publishes Lung Cancer Patient Management Study
2. Improving quality and access to advanced cancer care in India and South Asia
3. Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment
4. Etirinotecan Pegol (NKTR-102) Passes Interim Efficacy Analysis for BEACON Pivotal Phase 3 Clinical Study in Patients with Metastatic Breast Cancer
5. CRLX101 Meets Primary Endpoint in Phase 2 Clinical Trial in Relapsed Ovarian Cancer
6. arGEN-X Starts Phase Ib Expansion Cohorts With ARGX-110, a Novel Anti-CD70 Antibody, in Cancer Patients
7. QIAGEN and Exosome Diagnostics to Develop First-In-Class, Non-Invasive Diagnostics for Key Genetic Biomarkers in Lung and Other Cancers
8. Cell Therapeutics Reaches Agreement to Reacquire Rights to Two Anti-Cancer Compounds
9. Researchers Develop Tool To Determine Individual Risk Of Prostate Cancer Overdiagnosis
10. Lilly Oncology On Canvas: Expressions of a Cancer Journey Reaches Important Milestone With 2014 Competition
11. Loyola, Notre Dame Join Forces Against Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... , December 2, 2016 ... "In Vitro Diagnostics/IVD Market by Product (Instruments, Reagents, ... Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) - ... market is valued at USD 60.22 Billion in ... a CAGR of 5.5% during the forecast period ...
(Date:12/2/2016)... , December 2, 2016 ... Awards Committee honored excellence in research, development and innovation ... The gala dinner was held in the presence of ... the Russian Federation , Natalia Sanina, ... Mikhail Murashko , Head of Roszdravnadzor, National Service ...
(Date:12/2/2016)... RICHMOND, British Columbia , December 2, 2016 ... Produkt, den INSTI HIV-Selbsttest, bei den Mitgliedern des Apothekenbundes von Kenia eingeführt. ... ... INSTI HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ...      (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) ...
Breaking Medicine Technology:
(Date:12/4/2016)... ... December 03, 2016 , ... While James Earl Jones is known for myriad ... a show called "Front Page". One of the forthcoming episodes examines mammogram techniques; a ... plummeted in large part due to early detection. Like any other disease, treatments have ...
(Date:12/4/2016)... ... December 04, 2016 , ... Patients ... can now take advantage of a cosmetic procedure known as Carbon Dioxide ... reduces the appearance of age spots, fine lines, uneven coloration, wrinkles, scarring, ...
(Date:12/2/2016)... ... , ... Lori G. Cohen and Sara K. Thompson , ... American Conference Institute’s 21st Drug & Medical Device Litigation Conference , taking place ... conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation ...
(Date:12/2/2016)... AL (PRWEB) , ... December 02, 2016 , ... ... from across the Dothan-Wiregrass Area in Alabama are expected to attend the UNCF ... Schmitz, will help provide scholarship funds for area students and operating support to ...
(Date:12/2/2016)... ... ... The annual time frame to change Medicare health and prescription drug coverage, known ... Medicare beneficiaries who are looking to switch from their current plan to a Medicare ... during this period order for their new policy to go into effect in 2017. ...
Breaking Medicine News(10 mins):